Therefore, research to investigate the association of ERCC1, XRCC1 and GSTP1 polymorphisms with clinical treatment responses and adverse events from platinum-based chemotherapy especially in Thai patients with advanced epithelial ovarian cancer was needed. This evidence concerns the gene XRCC1 and ovarian carcinoma.